دورية أكاديمية

Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks

التفاصيل البيبلوغرافية
العنوان: Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks
المؤلفون: Leiter, Lawrence A, Gross, Jorge Luiz, Chow, Francis C C, Miller, Diane, Johnson, Susan L, Ahrén, Bo
المصدر: Journal of Diabetes and its Complications; 31(8), pp 1283-1285 (2017) ; ISSN: 1056-8727
بيانات النشر: Elsevier
سنة النشر: 2017
المجموعة: Lund University Publications (LUP)
مصطلحات موضوعية: Endocrinology and Diabetes, Basal insulin, Clinical trial, Combination therapy, Glucagon-like peptide-1 receptor agonist, Type 2 diabetes
الوصف: We have previously reported that once-weekly albiglutide was noninferior to thrice-daily lispro for glycemic lowering, with decreased weight and risk of hypoglycemia, in patients inadequately controlled on basal insulin over 26 weeks. Findings after 52 weeks reveal similar responses to albiglutide as an add-on to insulin glargine.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://lup.lub.lu.se/record/068b6333-3237-40d6-a68c-8ddf0f9d5956Test; http://dx.doi.org/10.1016/j.jdiacomp.2017.05.010Test; scopus:85020115367; pmid:28587789; wos:000406081200008
DOI: 10.1016/j.jdiacomp.2017.05.010
الإتاحة: https://doi.org/10.1016/j.jdiacomp.2017.05.010Test
https://lup.lub.lu.se/record/068b6333-3237-40d6-a68c-8ddf0f9d5956Test
رقم الانضمام: edsbas.227BA33F
قاعدة البيانات: BASE